Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

In vivo brain GPCR signaling elucidated by phosphoproteomics
Jeffrey J. Liu, Kirti Sharma, Luca Zangrandi, et al.
Science (2018) Vol. 360, Iss. 6395
Open Access | Times Cited: 117

Showing 1-25 of 117 citing articles:

The functional landscape of the human phosphoproteome
David Ochoa, Andrew F. Jarnuczak, Cristina Viéitez, et al.
Nature Biotechnology (2019) Vol. 38, Iss. 3, pp. 365-373
Open Access | Times Cited: 385
High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform
Sean J. Humphrey, Özge Karayel, David E. James, et al.
Nature Protocols (2018) Vol. 13, Iss. 9, pp. 1897-1916
Closed Access | Times Cited: 311
Illuminating the dark phosphoproteome
Elise J. Needham, Benjamin L. Parker, Timur Burykin, et al.
Science Signaling (2019) Vol. 12, Iss. 565
Open Access | Times Cited: 300
Sleep-wake cycles drive daily dynamics of synaptic phosphorylation
Franziska Brüning, Sara B. Noya, Tanja Bange, et al.
Science (2019) Vol. 366, Iss. 6462
Open Access | Times Cited: 242
The emerging role of mass spectrometry-based proteomics in drug discovery
Felix Meissner, Jennifer Geddes‐McAlister, Matthias Mann, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 9, pp. 637-654
Closed Access | Times Cited: 230
GPCRomics: An Approach to Discover GPCR Drug Targets
Paul A. Insel, Krishna Sriram, Matthew W. Gorr, et al.
Trends in Pharmacological Sciences (2019) Vol. 40, Iss. 6, pp. 378-387
Open Access | Times Cited: 156
Acquisition and Analysis of DIA-Based Proteomic Data: A Comprehensive Survey in 2023
Ronghui Lou, Wenqing Shui
Molecular & Cellular Proteomics (2024) Vol. 23, Iss. 2, pp. 100712-100712
Open Access | Times Cited: 39
Single-cell transcriptomic evidence for dense intracortical neuropeptide networks
Stephen J Smith, Uygar Sümbül, Lucas T. Graybuck, et al.
eLife (2019) Vol. 8
Open Access | Times Cited: 142
A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
Kendall L. Mores, Benjamin Cummins, Robert J. Cassell, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 101
27-Plex Tandem Mass Tag Mass Spectrometry for Profiling Brain Proteome in Alzheimer’s Disease
Zhen Wang, Kaiwen Yu, Haiyan Tan, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 10, pp. 7162-7170
Open Access | Times Cited: 97
Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion
Jeffrey J. Liu, Yi-Ting Chiu, Kelly M. DiMattio, et al.
Neuropsychopharmacology (2018) Vol. 44, Iss. 5, pp. 939-949
Open Access | Times Cited: 88
Oncogenic Mutations Rewire Signaling Pathways by Switching Protein Recruitment to Phosphotyrosine Sites
Alicia Lundby, Giulia Franciosa, Kristina B. Emdal, et al.
Cell (2019) Vol. 179, Iss. 2, pp. 543-560.e26
Open Access | Times Cited: 88
Biased ligands at opioid receptors: Current status and future directions
Tao Che, Hemlata Dwivedi‐Agnihotri, Arun K. Shukla, et al.
Science Signaling (2021) Vol. 14, Iss. 677
Open Access | Times Cited: 87
Gi/o-Protein Coupled Receptors in the Aging Brain
Patrícia Gnieslaw de Oliveira, Marta Longchong Ramos, A Amaro, et al.
Frontiers in Aging Neuroscience (2019) Vol. 11
Open Access | Times Cited: 81
Deconstruction of Heterogeneity of Size-Dependent Exosome Subpopulations from Human Urine by Profiling N-Glycoproteomics and Phosphoproteomics Simultaneously
Haoyang Zheng, Sheng Guan, Xuantang Wang, et al.
Analytical Chemistry (2020) Vol. 92, Iss. 13, pp. 9239-9246
Closed Access | Times Cited: 79
Personalized phosphoproteomics identifies functional signaling
Elise J. Needham, Janne R. Hingst, Benjamin L. Parker, et al.
Nature Biotechnology (2021) Vol. 40, Iss. 4, pp. 576-584
Closed Access | Times Cited: 71
Charge-specific adverse effects of polystyrene nanoplastics on zebrafish (Danio rerio) development and behavior
Miaomiao Teng, Xiaoli Zhao, Fengchang Wu, et al.
Environment International (2022) Vol. 163, pp. 107154-107154
Open Access | Times Cited: 69
Subcellular location defines GPCR signal transduction
Arthur Radoux-Mergault, Lucie Oberhauser, Simone Aureli, et al.
Science Advances (2023) Vol. 9, Iss. 16
Open Access | Times Cited: 34
µPhos: a scalable and sensitive platform for high-dimensional phosphoproteomics
Denys Oliinyk, Andreas Will, Felix R Schneidmadel, et al.
Molecular Systems Biology (2024) Vol. 20, Iss. 8, pp. 972-995
Open Access | Times Cited: 9
EPSD: a well-annotated data resource of protein phosphorylation sites in eukaryotes
Shaofeng Lin, Chenwei Wang, Jiaqi Zhou, et al.
Briefings in Bioinformatics (2019) Vol. 22, Iss. 1, pp. 298-307
Closed Access | Times Cited: 69
Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion
Antony D. Abraham, Selena S. Schattauer, Kathryn L. Reichard, et al.
Journal of Neuroscience (2018) Vol. 38, Iss. 37, pp. 8031-8043
Open Access | Times Cited: 68
DeepPhospho accelerates DIA phosphoproteome profiling through in silico library generation
Ronghui Lou, Weizhen Liu, Rongjie Li, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 54
A review on recent trends in the phosphoproteomics workflow. From sample preparation to data analysis
Jiřı́ Urban
Analytica Chimica Acta (2021) Vol. 1199, pp. 338857-338857
Closed Access | Times Cited: 48
Structural Insights Accelerate the Discovery of Opioid Alternatives
Tao Che, Bryan L. Roth
Annual Review of Biochemistry (2021) Vol. 90, Iss. 1, pp. 739-761
Open Access | Times Cited: 43
Targeting the M1 muscarinic acetylcholine receptor in Alzheimer’s disease
Louis Dwomoh, Gonzalo S. Tejeda, Andrew Tobin
Neuronal Signaling (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 34
Page 1 - Next Page

Scroll to top